Spyre Therapeutics, Inc. (SYRE)
80.45
-5.45
(-6.34%)
USD |
NASDAQ |
Oct 13, 16:00
80.53
+0.08
(+0.10%)
After-Hours: 20:00
Spyre Therapeutics EPS Diluted (TTM) : -2.18 for June 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.18 |
| March 31, 2026 | -2.358 |
| December 31, 2025 | -2.078 |
| September 30, 2025 | -2.178 |
| June 30, 2025 | -3.050 |
| March 31, 2025 | -3.035 |
| December 31, 2024 | -3.159 |
| September 30, 2024 | 9.210 |
| June 30, 2024 | 0.925 |
| March 31, 2024 | -55.27 |
| December 31, 2023 | -59.44 |
| September 30, 2023 | -78.22 |
| June 30, 2023 | -73.71 |
| March 31, 2023 | -23.71 |
| December 31, 2022 | -28.08 |
| September 30, 2022 | -31.24 |
| June 30, 2022 | -34.12 |
| March 31, 2022 | -29.93 |
| December 31, 2021 | -27.62 |
| September 30, 2021 | -29.10 |
| June 30, 2021 | -28.63 |
| March 31, 2021 | -36.14 |
| December 31, 2020 | -43.34 |
| September 30, 2020 | -49.98 |
| Date | Value |
|---|---|
| June 30, 2020 | -59.13 |
| March 31, 2020 | -62.74 |
| December 31, 2019 | -63.38 |
| September 30, 2019 | -60.41 |
| June 30, 2019 | -57.56 |
| March 31, 2019 | -55.27 |
| December 31, 2018 | -52.65 |
| September 30, 2018 | -46.90 |
| June 30, 2018 | -45.35 |
| March 31, 2018 | -45.67 |
| December 31, 2017 | -45.25 |
| September 30, 2017 | -45.75 |
| June 30, 2017 | -45.50 |
| March 31, 2017 | -45.25 |
| December 31, 2016 | -211.00 |
| September 30, 2016 | -208.04 |
| June 30, 2016 | -202.52 |
| March 31, 2016 | -193.63 |
| December 31, 2015 | -21.06 |
| September 30, 2015 | -19.59 |
| June 30, 2015 | -13.35 |
| March 31, 2015 | -10.74 |
| December 31, 2014 | -5.813 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| AbbVie, Inc. | 3.537 |
| Incyte Corp. | 7.846 |
| SELLAS Life Sciences Group, Inc. | -0.2121 |
| Relay Therapeutics, Inc. | -1.567 |
| ACADIA Pharmaceuticals, Inc. | 2.220 |